International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Session 4 Sabine Walser Council of Europe / Legal framework necessary for effective collaboration – MEDICRIME Convention
Session 4: Domenico Di Giorgio AIFA Italy / SPOC model cooperation against counterfeit medicines, The institutional coordination schemes in Italy
Session 3: Salmah Bahri - Ministry of Health, Malaysia / Monitoring of Counterfeit Medicines in Malaysia, Public-Private Sector Cooperation
Session 4: Sheuan Lee, International Council of Nurses (ICN) / Practices and Technologies for Prevention, Detection, Control and Monitoring of fake medicines: Perspective of HCPs
Session 3: Fu-Wen Chang, nternational Federation of Pharmaceutical Wholesalers (IFPW) / Implemention of Good Practices for Safe Medicines
Session 2: Mike Rose, Johnson & Johnson / Serialization and Traceability GS1 Standards: A Manufacturer’s Perspective
Session 1 - Mark Paxton, US FDA / APEC Roadmap to Promote Global Medical Product Quality and Supply Chain Security
No hay ninguna infografía aún
No hay ningún documento aún
Aún no hay me gusta
Información personal
Organización/Lugar de trabajo
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)Ubicación
Geneva SwitzerlandSector
Medical / Health Care / Pharmaceuticals
Sitio web
www.ifpma.orgAcerca de
IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.